샘플 요청 목록

 카트 문의
시장보고서
상품코드
1795194

백신 바이알 모니터 시장

Vaccine Vial Monitors
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 273 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

백신 바이알 모니터 세계 시장은 2030년까지 3억 4,010만 달러에 달할 전망

2024년에 2억 3,300만 달러로 추정되는 백신 바이알 모니터 세계 시장은 2030년에는 3억 4,010만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 6.5%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 멀티 도스 모니터는 CAGR 5.0%를 기록하며 분석 기간 종료시에는 1억 8,810만 달러에 달할 것으로 예측됩니다. 일회 투여 모니터 부문의 성장률은 분석 기간 동안 CAGR 8.6%로 추정됩니다.

미국 시장은 6,350만 달러로 추정, 중국은 CAGR 10.0%로 성장 예측

미국의 백신 바이알 모니터 시장은 2024년에 6,350만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간 2024년부터 2030년까지 CAGR 10.0%로 추정되며, 2030년에는 6,920만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.3%와 6.2%로 예측됩니다. 유럽에서는 독일이 CAGR 4.2%로 성장할 것으로 예측됩니다.

세계의 백신 바이알 모니터 시장 - 주요 동향과 촉진요인 정리

백신 바이알 모니터가 전 세계 백신의 안전성과 효능을 보장하는 데 중요한 이유는 무엇일까?

백신 바이알 모니터(VVM)는 제조부터 투여까지 백신의 효능을 유지함으로써 전 세계 예방접종 프로그램에 필수적인 역할을 하고 있습니다. 색이 변하는 이 작은 인디케이터는 백신 바이알에 부착되어 시간이 지남에 따라 누적되는 열 노출을 시각적으로 보여줌으로써 의료진이 백신이 위험에 노출되었는지 여부를 판단하는 데 도움을 줍니다. 전 세계 많은 지역, 특히 외딴 지역이나 자원이 한정된 지역에서는 끊김 없는 콜드체인을 유지하는 것이 큰 과제입니다. 온도 변동은 백신의 효능을 떨어뜨리거나 완전히 비활성화시킬 수 있지만, 백신의 열화 징후가 반드시 눈에 보이는 것은 아닙니다. VVM은 고도의 기술을 필요로 하지 않으며, 현장 의료진이 정보에 입각한 의사결정을 내릴 수 있도록 도와주는 간단하고 비용 효율적인 도구로 작용합니다. 효과가 없는 백신의 투여를 방지함으로써 공중 보건을 보호하고 예방접종 프로그램에 대한 신뢰를 강화할 수 있습니다. WHO와 UNICEF와 같은 국제보건기구는 특히 홍역, 소아마비, 결핵과 같은 질병을 대상으로 하는 예방접종 프로그램에서 VVM을 표준 요구사항으로 삼고 있습니다. 특히 전염병이나 전염병 발생에 대응하여 백신 접종 규모를 확대하는 국가가 늘어남에 따라 백신 무결성 유지의 중요성이 더욱 부각되고 있습니다. VVM은 백신 유통의 모든 단계에서 투명성, 책임성, 안전성을 제공하고, 보관 사슬에서 필수적인 체크포인트 역할을 하고 있습니다.

백신 바이알 모니터의 기능은 어떻게 향상되고 있는가?

백신 바이알 모니터의 기능성과 신뢰성은 재료과학, 열화학, 지표 설계의 발전으로 크게 향상되었습니다. 기존 VVM은 누적된 열 노출에 반응하여 색이 변하는 시간 온도 민감성 염료에 의존하는 반면, 차세대 모니터는 보다 정확하고 해석하기 쉬우며 광범위한 온도 프로파일을 지원하도록 설계되었습니다. 이러한 개선을 통해 mRNA 기반 제제와 같이 초저온 보존이 필요한 백신을 포함하여 다양한 유형의 백신에 적합한 VVM을 개발할 수 있게 되었습니다. 접착제와 잉크의 배합이 개선되어 열악한 조건에서도 인디케이터가 단단히 고정되어 가시성을 유지할 수 있게 되었습니다. 제조업체들은 또한 의료진이 바이알의 온도 이력, 유효기간 만료 상태, 배치의 출처에 대한 데이터를 스캔하여 기록할 수 있는 QR코드와 같은 디지털 기능을 VVM에 통합하기 위해 노력하고 있습니다. 일부 차세대 VVM은 근거리 무선 통신(NFC) 칩과 블루투스 기능을 탑재하여 개발되고 있으며, 스마트폰이나 연결된 장치를 통해 실시간 모니터링이 가능합니다. 이러한 기술은 데이터 수집을 개선하고, 낭비를 줄이며, 물류 혼란에 신속하게 대응하고자 하는 백신 판매업체와 보건부에 특히 유용합니다. 또한, VVM의 디자인은 보다 명확한 시각적 표시기, 변조 방지 기능, 다양한 헬스케어 환경을 지원하는 다국어 설명서 등 보다 사용자 중심적으로 변화하고 있습니다. 이러한 기술 발전은 콜드체인에서 지능형 도구로서 VVM의 역할을 강화하고, 백신의 품질 보증을 강화하며, 인위적인 실수나 보관 실패에 따른 위험을 줄여줍니다.

백신 바이알 모니터의 수요를 주도하는 세계 보건 이니셔티브와 시장은?

전 세계적으로 예방접종 활동의 규모가 확대되고 복잡해지면서 백신, 바이알, 모니터에 대한 수요가 크게 증가하고 있습니다. 특히 인프라 제약으로 인해 콜드체인 장애의 위험이 높은 지역에서는 이러한 경향이 두드러집니다. 특히 Gavi, WHO, UNICEF 등의 조직이 주도하는 대규모 예방접종 이니셔티브는 아프리카, 남아시아, 라틴아메리카 일부 지역에서 배포되는 백신의 조달 기준에 VVM을 통합하고 있습니다. 이러한 지역에서는 전력 공급의 변동성, 냉장 능력의 제한, 긴 운송 경로 등에 직면하는 경우가 많으며, VVM은 열악한 조건에서 백신의 효능을 보호하는 데 필수적입니다. 로타바이러스, HPV, 황열병 등 국가 예방접종 프로그램을 시행하는 국가에서 VVV는 일선 의료진이 백신을 안전하게 평가하고 투여할 수 있도록 신뢰성을 제공합니다. COVID-19 백신의 출시로 인해 신뢰할 수 있는 모니터링의 필요성이 더욱 강조되었고, 많은 mRNA 백신은 초기에 초저온 보관이 필요했지만, 물류의 적응과 새로운 제형으로 인해 현재 더 광범위한 공중 보건에 사용할 수 있게 되어 전문 VVM에 대한 수요가 증가하고 있습니다. 중산층 국가들도 콜드체인 현대화 노력의 일환으로 이러한 지표를 채택하고 있으며, 많은 경우 양국 간 보건 파트너십이나 해외 원조를 통해 지원받고 있습니다. 또한, 제약사 및 제조 위탁 기관은 국제 표준을 충족하고 제품의 추적성을 보장하기 위해 VVM을 제조 및 유통 프로토콜에 통합하고 있습니다. 정부 프로그램뿐만 아니라 인도적 지원 단체와 재난 대응 기관도 긴급 상황에서 안전한 예방접종을 제공하기 위해 VVM을 활용하고 있습니다. 이러한 광범위하고 다양한 사용 사례로 인해 세계 VVM 시장은 지속적인 수요와 기술 혁신을 보장하고 있습니다.

백신 바이알 및 모니터 시장의 성장을 촉진하는 주요 요인은 무엇인가?

백신 바이알 및 모니터 시장의 성장은 예방접종 프로그램 확대, 세계 보건에 대한 투자 증가, 규제 요건 강화, 콜드체인 취약성에 대한 인식 증가 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 보편적 백신 접종을 달성하고 백신으로 예방 가능한 질병을 퇴치하기 위해 노력하는 국가가 늘어남에 따라 VVM과 같은 신뢰할 수 있는 품질 보증 도구의 필요성이 계속 증가하고 있습니다. Gavi의 COVAX 프로그램, 세계은행의 팬데믹 대책과 같은 이니셔티브를 통한 세계 자금 지원도 중저소득 국가에서 VVM을 광범위하게 조달하고 실행할 수 있도록 돕고 있습니다. WHO와 각국 보건부를 포함한 규제 기관은 특히 공공 부문을 통해 유통되는 모든 열감수성 백신에 VVM 사용을 의무화하고 있습니다. 이러한 정책으로 인해 각 제조사들은 백신 라인 전체에 VVM 통합을 표준화하도록 장려하고 있습니다. 또한, 저온 또는 초저온 보관이 필요한 백신에 대한 수요가 급증하면서 종합적인 콜드체인 검증의 일환으로 온도 민감도 지표의 중요성이 부각되고 있습니다. 또한, VVM의 디자인과 사용 편의성의 기술적 향상도 성장을 견인하고 있습니다. 새로운 모델은 성능과 데이터 추적 기능이 강화되어 국제보건기구와 상업적 구매자 모두에게 어필할 수 있습니다. 또한, 백신 폐기물 감소와 공급망 최적화에 대한 관심이 높아짐에 따라 VVM은 지속가능성 목표에 기여하는 비용 절감 도구로 자리매김하고 있습니다. 이러한 요인들은 백신 바이알 모니터의 전략적 가치를 강화하여 백신 안전, 물류 및 공중 보건 보증에 필수적인 자산으로 지속적인 성장을 보장하고 있습니다.

부문

유형(멀티 도스 모니터, 싱글 도스 모니터), 용도(예방 백신 용도, 치료 백신 용도)

조사 대상 기업 사례

  • 3M Company
  • Avantor(VWR)
  • Berlinger & Co. AG
  • Cardinal Health
  • Catalent, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Elitech Technology, Inc.
  • ELPRO-BUCHS AG
  • Gerresheimer AG
  • Lisaline Lifescience Technologies Pvt Ltd
  • LogTag Recorders(North America Inc.)
  • Nipro Corporation
  • Pacific Vial Manufacturing
  • Parsyl, Inc.
  • Schott AG
  • Sensitech, Inc.
  • Stevanato Group
  • Temptime Corporation(Zebra Technologies)
  • Thermo Fisher Scientific Inc.

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.29

Global Vaccine Vial Monitors Market to Reach US$340.1 Million by 2030

The global market for Vaccine Vial Monitors estimated at US$233.0 Million in the year 2024, is expected to reach US$340.1 Million by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Multi-Dose Monitors, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$188.1 Million by the end of the analysis period. Growth in the Single Dose Monitors segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$63.5 Million While China is Forecast to Grow at 10.0% CAGR

The Vaccine Vial Monitors market in the U.S. is estimated at US$63.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$69.2 Million by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Vaccine Vial Monitors Market - Key Trends & Drivers Summarized

Why Are Vaccine Vial Monitors Critical in Ensuring Vaccine Safety and Efficacy Worldwide?

Vaccine Vial Monitors (VVMs) play an indispensable role in global immunization programs by ensuring that vaccines remain effective from production to administration. These small, color-changing indicators are affixed to vaccine vials and provide a visual cue about cumulative heat exposure over time, helping health workers determine whether a vaccine has been compromised. In many parts of the world, particularly in remote or resource-limited areas, maintaining an unbroken cold chain is a significant challenge. Temperature excursions can degrade vaccines, rendering them less effective or even completely inactive, and yet the signs of degradation are not always visible. VVMs act as simple, cost-effective tools that empower frontline health workers to make informed decisions without requiring sophisticated technology. They help prevent the administration of ineffective vaccines, thus safeguarding public health and reinforcing trust in immunization programs. International health organizations such as WHO and UNICEF have made VVMs a standard requirement for vaccines supplied through their programs, especially those targeting diseases like measles, polio, and tuberculosis. As more countries scale up vaccination efforts, particularly in response to pandemics or outbreaks, the importance of maintaining vaccine integrity has become even more pronounced. VVMs serve as an essential checkpoint in the chain of custody, offering transparency, accountability, and safety across all stages of vaccine distribution.

How Are Technological Improvements Enhancing the Capabilities of Vaccine Vial Monitors?

The functionality and reliability of Vaccine Vial Monitors have been significantly improved through advances in materials science, thermal chemistry, and indicator design. Traditional VVMs rely on a time-temperature sensitive dye that changes color in response to cumulative heat exposure, but newer generations of monitors are more precise, easier to interpret, and designed for a broader range of temperature profiles. These improvements have enabled the development of VVMs suited for various types of vaccines, including those requiring ultracold storage such as mRNA-based formulations. Enhanced adhesives and ink formulations now ensure that indicators remain firmly attached and legible even under harsh conditions. Manufacturers are also working on integrating digital features with VVMs, such as QR codes that allow health workers to scan and log data related to a vial’s temperature history, expiration status, and batch origin. Some next-generation VVMs are being developed with near-field communication (NFC) chips or Bluetooth capabilities, enabling real-time monitoring via smartphones or connected devices. These technologies are particularly valuable for vaccine distributors and health ministries aiming to improve data collection, reduce waste, and respond quickly to logistical disruptions. Furthermore, VVM design is becoming more user-centric, with clearer visual indicators, tamper-evidence features, and multilingual instructions to support diverse healthcare settings. These technological advancements are reinforcing the role of VVMs as intelligent tools in the cold chain, enhancing vaccine quality assurance and reducing the risks associated with human error or storage failure.

Which Global Health Initiatives and Markets Are Driving Demand for Vaccine Vial Monitors?

The increasing scale and complexity of global vaccination efforts are driving significant demand for Vaccine Vial Monitors, especially in regions where infrastructure limitations elevate the risk of cold chain failure. Large-scale immunization initiatives, particularly those spearheaded by organizations such as Gavi, WHO, and UNICEF, have integrated VVMs into the procurement criteria for vaccines distributed in Africa, South Asia, and parts of Latin America. These regions often face fluctuating power supplies, limited refrigeration capacity, and long transportation routes, making VVMs essential for protecting vaccine efficacy under challenging conditions. In countries implementing national immunization programs for diseases like rotavirus, HPV, and yellow fever, VVMs provide frontline health workers with the confidence to assess and administer vaccines safely. The rollout of COVID-19 vaccines further emphasized the need for reliable monitoring, and while many mRNA vaccines required ultracold storage initially, logistical adaptations and new formulations are now bringing them into broader public health use, reinforcing demand for specialized VVMs. Middle-income nations are also adopting these indicators as part of broader cold chain modernization efforts, often supported by bilateral health partnerships and foreign aid. Additionally, pharmaceutical companies and contract manufacturing organizations are embedding VVMs in their production and distribution protocols to meet international standards and ensure product traceability. Beyond government programs, humanitarian aid groups and disaster response agencies also rely on VVMs to deliver safe immunizations in emergency settings. These widespread and varied use cases are ensuring sustained demand and innovation in the global VVM market.

What Key Factors Are Driving Growth in the Vaccine Vial Monitors Market?

The growth in the vaccine vial monitors market is driven by several critical factors, including expanding immunization programs, rising global health investment, increased regulatory requirements, and heightened awareness about cold chain vulnerabilities. As more countries commit to achieving universal vaccine coverage and eradicating vaccine-preventable diseases, the need for reliable quality assurance tools like VVMs continues to increase. Global funding from initiatives such as Gavi’s COVAX program and the World Bank’s pandemic preparedness efforts is also enabling broader procurement and implementation of VVMs in low- and middle-income countries. Regulatory bodies, including WHO and national ministries of health, are mandating the use of VVMs on all heat-sensitive vaccines, especially those distributed through public-sector channels. These policies are encouraging manufacturers to standardize VVM integration across their vaccine lines. Additionally, the surge in demand for vaccines requiring cold or ultracold storage is spotlighting the importance of temperature-sensitive indicators as part of comprehensive cold chain validation. Technological improvements in VVM design and usability are also fueling growth, as newer models offer enhanced performance and data tracking capabilities that appeal to both global health organizations and commercial buyers. Moreover, the increasing focus on vaccine waste reduction and supply chain optimization is positioning VVMs as cost-saving tools that also contribute to sustainability goals. Together, these factors are reinforcing the strategic value of vaccine vial monitors and ensuring their continued growth as indispensable assets in vaccine safety, logistics, and public health assurance.

SCOPE OF STUDY:

The report analyzes the Vaccine Vial Monitors market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Multi-Dose Monitors, Single Dose Monitors); Application (Preventive Vaccine Application, Therapeutic Vaccine Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 3M Company
  • Avantor (VWR)
  • Berlinger & Co. AG
  • Cardinal Health
  • Catalent, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Elitech Technology, Inc.
  • ELPRO-BUCHS AG
  • Gerresheimer AG
  • Lisaline Lifescience Technologies Pvt Ltd
  • LogTag Recorders (North America Inc.)
  • Nipro Corporation
  • Pacific Vial Manufacturing
  • Parsyl, Inc.
  • Schott AG
  • Sensitech, Inc.
  • Stevanato Group
  • Temptime Corporation (Zebra Technologies)
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Vaccine Vial Monitors - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Global Immunization Programs Throw the Spotlight on Heat-Sensitive Labeling and Monitoring Solutions
    • Rising Demand for Cold Chain Assurance Spurs Widespread Use of Vaccine Vial Monitors in Low-Resource Settings
    • Here's How WHO Prequalification and Gavi Procurement Are Driving Standardization and Global Adoption of VVMs
    • Expansion of Temperature-Sensitive Vaccine Portfolios Strengthens the Business Case for Advanced Vial-Level Monitoring
    • Growing Need for Visual, Low-Cost Quality Indicators in Remote Areas Propels Demand for Color-Change VVMs
    • Here's the Story: How mRNA and ULT Vaccine Rollouts Are Creating Demand for High-Sensitivity Monitoring Labels
    • Digitization of Vaccine Supply Chains Drives Interest in Smart VVMs with Integrated Data Logging or QR Code Traceability
    • Public Health Campaigns and Mobile Vaccination Units Expand the Addressable Market for Field-Usable Monitoring Tools
    • Rising Emphasis on Zero-Waste and Last-Mile Integrity Supports Innovation in Multi-Stage or Multi-Threshold VVMs
    • Emerging Interest in Time-Temperature Indicators (TTIs) for Biologics Fuels Broader Application of VVM Technology
    • Global Push for Vaccine Equity and Reliability Encourages Localization and Technology Transfer of VVM Production
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vaccine Vial Monitors Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vaccine Vial Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Multi-Dose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Multi-Dose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Multi-Dose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Single Dose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Single Dose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Single Dose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Preventive Vaccine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Preventive Vaccine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Preventive Vaccine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Therapeutic Vaccine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Therapeutic Vaccine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Therapeutic Vaccine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • CHINA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: China 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Vaccine Vial Monitors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: France 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Vaccine Vial Monitors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • INDIA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: India 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Vaccine Vial Monitors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Vaccine Vial Monitors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Vaccine Vial Monitors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Vaccine Vial Monitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Vaccine Vial Monitors by Type - Multi-Dose Monitors and Single Dose Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Vaccine Vial Monitors by Type - Percentage Breakdown of Value Sales for Multi-Dose Monitors and Single Dose Monitors for the Years 2014, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Vaccine Vial Monitors by Application - Preventive Vaccine Application and Therapeutic Vaccine Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Vaccine Vial Monitors by Application - Percentage Breakdown of Value Sales for Preventive Vaccine Application and Therapeutic Vaccine Application for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제